Capitol Hill Report

Advocacy

Read the Academy's bi-weekly update on legislative and regulatory advocacy for neurology.

Image of the front of the United States Capitol Hill building

October 20, 2025

Joint forum on neuroscience research

We’ve got your back on Capitol Hill—and we’re in overdrive advocating for you and your patients. Capitol Hill Report is your source for all things neurology advocacy, so keep reading and sharing to stay up to date. Plus, we want to hear from you: Let us know if your practice, research, or patients are affected by recent policy changes.  

Issue in focus

AAN and SfN joint virtual forum: Neuroscience research in times of uncertainty 
Brain health for all is our mission—but we can’t complete it without robust federal funding for neuroscience research. This research is essential for advancing science, improving patient care, and sustaining the future of neuroscience and neurology. The process that determines its federal funding, however, can be complex and unpredictable.

Strong, coordinated advocacy is necessary to support robust research funding. To engage our members and lead on this issue, the AAN is hosting a joint virtual forum with the Society for Neuroscience (SfN) on Thursday, October 30, at 3:30 p.m. CT to discuss the importance of federal funding to neuroscience research and explain how our members can best influence the federal appropriations process. 

This virtual forum will help participants:

  • Understand why federal funding matters for research and patient outcomes
  • Learn how the federal appropriations process works and understand the implications of a lapse in funding or a government shutdown
  • Explore proven advocacy strategies and identify practical ways they can take action to strengthen support for science

Hear insights from AAN President Natalia S. Rost, MD, MPH, FAAN, FAHA; SfN President John Morrison, PhD; AAN Science Committee Chair Paul M. George, MD, PhD, MSE, FAAN; AAN Advocacy Committee Vice Chair Justin T. Jordan, MD, MPH, FAAN; and SfN Government and Public Affairs Committee Chair Diane Lipscomb, PhD. The session will end with a moderated Q&A to connect participants directly with advocacy leaders.

for this event. If you have any questions, please email us at advocacy@aan.com

 
Latest advocacy news

Join us for Neurology on the Hill!
It’s that time of the year again to apply to join the AAN in Washington, DC, for our annual fly-in. Neurology on the Hill will take place February 22 to 24, 2026—and we need neurologists from around the country to lend their voices. Apply now, or encourage your colleagues to apply, to advocate on behalf of your patients and profession. Learn more.

Share your story on the government shutdown and telehealth lapse
The AAN is collecting stories from our members about how the government shutdown and the lapse in telehealth flexibilities are affecting you and your patients. Please email us to share your story today. 

Application deadline is tomorrow for AAN awards
Apply for AAN awards by Tuesday, October 21, for the chance to be recognized at the Annual Meeting. With more than 60 prestigious opportunities available in scientific research, neurology education, quality, practice, health equity, and more, there’s an award for everyone. New for 2026 are three awards for advanced practice providers. In particular, make sure to check out the Kenneth M. Viste, Jr., MD, Patient Advocate of the Year Award

New guidance on Medicare claims amid telehealth lapse
The Centers for Medicare & Medicaid Services issued new guidance to Medicare Administrative Contractors, instructing them to hold claims for services provided on or after October 1 that are impacted by the expiration of telehealth flexibilities due to the government shutdown. For all other services, Medicare claims will continue to be processed and paid. To learn more about the impact of the shutdown, please visit the AAN’s shutdown resources page. To urge your members of Congress to extend crucial telehealth flexibilities, please visit our


What we're reading

  • FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease ()

  • Musk’s Neuralink submits brain implant patient data to journal ()
  • Prescription Drug Coverage Options Are Shrinking for Medicare Shoppers ()

Past Capitol Hill Reports

2025

2024

2023

2022